RxDoctor Payments Data

Kenneth Lingenfelter, DO

Orthopaedic Surgery · Newark, DENPI 1326294299

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,225 of the $67,202 with a category attached, or 77.7%. 16 manufacturers reported payments, led by Globus Medical at 57.1% of the total. Reporting peaked in 2023 at $30,119 and has fallen 66.5% since, to $10,100 in 2025. Among orthopaedic surgery clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$67,202in general payments, 2019–2025

Across 221 payments — averaging $304.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$38K
  • CTL Medical Corporation$18K
  • Stryker$9K
  • Medtronic$511
  • Cerapedics Inc.$376
  • Alphatec Spine, Inc$195
  • plus $840 from 10 others

What the payments were for

  • Consulting fees$52,22578%
  • Travel & lodging$3,9916%
  • Food & beverage$10,92116%
  • Education$650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$67,202 in reported general payments places this provider in the 90th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$161,905
Medicare patients
255
Services billed
964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin49$813
Prednisone22$61
Meloxicam18$20

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →